Pre-eclampsia is a condition that affects some people in pregnancy (usually after 20 weeks) or soon after their baby is ...

Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that ...